Farmaceutica R

Research Farmaceutica R (RMAH) on Bullrun: valuation model: 20.4% undervalued, market cap RON 74.03M, P/E 9.9, dividend yield 6.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRMAH
• ExchangeRO
• CountryRomania
• SectorHealthcare
• IndustryMedical Distribution
• CurrencyRON
• Valuation signal20.4% undervalued
• Market capRON 74.03M
• P/E9.9
• Dividend yield6.4%
• Financial periodFY2022
• RevenueRON 540.05M
• Revenue growth12.9%
• Net incomeRON 5.81M
• Gross margin1.9%

Valuation Snapshot

Bullrun's latest valuation model marks Farmaceutica R as 20.4% undervalued; latest market cap is RON 74.03M; P/E is 9.9; dividend yield is 6.4%.

About Farmaceutica R

Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics and warehousing, promotion and marketing of drugs, and pharmaceutical products registration services. The company was incorporated in 1991 and is headquartered in Deva, Romania.

Frequently asked questions

Is Farmaceutica R overvalued or undervalued?

Bullrun's valuation model currently marks Farmaceutica R as 20.4% undervalued.

What is Farmaceutica R's market cap?

Farmaceutica R's market capitalization is RON 74.03M.

What is Farmaceutica R's P/E ratio?

Farmaceutica R's price-to-earnings (P/E) ratio is 9.9.

Does Farmaceutica R pay a dividend?

Farmaceutica R has a dividend yield of 6.4%.

What does Farmaceutica R do?

Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials;